Serina Therapeutics (SER) Prepaid Assets (2017 - 2026)
Serina Therapeutics (SER) posted Prepaid Assets of $309000.0 for Q4 2025, up 81.76% sequentially from $170000.0 in Q3 2025, and up 301.3% YoY from $77000.0 in Q4 2024.
Serina Therapeutics (SER) Prepaid Assets (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $309000.0 in Q4 2025.
- Quarterly Prepaid Assets rose 301.3% year-over-year to $309000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $309000.0 (up 301.3% YoY) and the FY2025 annual result came in at $309000.0, up 301.3% from the prior year.
- Prepaid Assets improved to $309000.0 in Q4 2025 per SER's latest filing, from $170000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.8 million in Q2 2024 and troughed at $77000.0 in Q4 2024.
- A 5-year average of $948631.6 and a median of $930000.0 in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2025: Prepaid Assets soared 903.72% in 2021, then sank 93.68% in 2025.
- Over 5 years, Prepaid Assets stood at $1.6 million in 2021, then climbed by 11.02% to $1.8 million in 2022, then tumbled by 62.69% to $673000.0 in 2023, then slumped by 88.56% to $77000.0 in 2024, then soared by 301.3% to $309000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $309000.0, $170000.0, and $177000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Dec 31, 2025 | 309,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 166,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 720,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 720,000.00 |
| Jun 30, 2021 | 930,000.00 |
| Mar 31, 2021 | 1.29 Mn |